New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The system is powered by BrainSense technology, which has received approval from USFDA
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
By cutting pain crises & boosting haemoglobin
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Subscribe To Our Newsletter & Stay Updated
